Skip to main content
Premium Trial:

Request an Annual Quote

Genalice Map 2.4.0

Genalice has released Genalice 2.4.0, the latest iteration of of its software for secondary analysis of next-generation sequencing data. This release includes a new somatic calling module that helps users distinguish between variants found in normal and tumor tissue samples. According to the company, the new module outperforms existing tools such as MuTecT, FreeBayes, and VarScan in terms of both speed and accuracy. Other updates to the software include a tool that lets users create profiles for defined cohorts for targeted cell amplification and suppression as well as a tool for detecting copy number variants.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more